°®¶¹´«Ã½










ASM CVS Scientific Program

The ASM Clinical Virology Symposium features a rich scientific program addressing the timeliest clinical and diagnostic virology issues. Join us to hear from experts on the latest research topics, ranging from challenges and opportunities in clinical virology to clinical aspects of viral diseases and laboratory diagnosis of viral infections.


Clinical Virology Symposium Online Itinerary Planner

The Online Itinerary Planner improves the overall attendee experience. Users can now search sessions by day and session type, making it easier than ever to plan your schedule! It also provides more information and now includes poster presenter info.


Program Schedule

Note: The following schedule is a long-form comprehensive look at the meeting, including session times, speakers and topics. 

Networking Meals—connect with colleagues from around the globe with light refreshments during the welcome reception and closing reception. Also included with registration, continental breakfast will be provided on Oct. 8—Oct. 10 before each mornings’ scientific sessions, and lunches will be provided Oct. 9 and 10 in the Exhibit & Poster Hall, Tuesday and Wednesday. Expand your circle of influence and establish relationships that will last throughout your career.

For a broader overview of the meeting please visit our Schedule-at-a-Glance.

 

Jump to Day:


Monday, Oct. 7


5–6:15 p.m.

  • Opening Remarks
    Benjamin Pinsky, M.D., Ph.D., Stanford University School of Medicine, CVS 2024 Program Committee Chair
    Christopher C. DeCesaris, American Society for °®¶¹´«Ã½

  • Keynote Speaker Introduction
    Amy Leber, Ph.D., Nationwide Children’s Hospital

  • SARS-CoV-2 Evolution: Implications for Public Health, Diagnostics, Immunity, and Vaccines
    David Wentworth, Ph.D., Director of the Corona Virus and Other Respiratory Diseases Division (CORVD), U.S. Centers for Disease Control and Prevention

  • Recognition: Steven Specter, Ph.D.
6:15–7:45 p.m.

Welcome Reception in Exhibit Hall

   

Back to Top

 

Tuesday, Oct. 8


7:30–8 a.m.

Continental Breakfast

8–10 a.m.

 

Moderator: Heba Mostafa, M.D., Ph.D., D(ABMM), The Johns Hopkins University School of Medicine

  • 8–8:30 a.m. | Virologic Point of Care Testing for Equity and Access
    Omai Garner, Ph.D., UCLA Health System

  • 8:30–10 a.m. | Panel Discussion: Practical Issues in Clinical Virology
    Joseph Yao, M.D., Mayo Clinic
    Susan Realegeno, Ph.D., D(ABMM), Quest Diagnostics
    Junko Jarrett, M.D., The Johns Hopkins Hospital
    Nicole M. Zinsmaster, Mayo Clinic
10 a.m.–2 p.m.

Exhibit and Poster Hall

  • 10–10:30 a.m. | Morning Break in Exhibit Hall

  • 12:30–1:30 p.m. | Luncheon in Exhibit Hall
10:15 a.m.–12 p.m.

Industry & Science Workshops*

 
  • 10:15-11 a.m. |

  • 11:15 a.m.–12 p.m. |
2:15–4:15 p.m.

Moderator: Melissa Miller, Ph.D., D(ABMM), FAAM

  • 2:15–4:15 p.m. | Panel Discussion: Impact of the FDA Rule Ending Regulatory Enforcement Discretion of Laboratory Developed Tests
    Erin H. Graf, Ph.D., D(ABMM), Director, Mayo Clinic Arizona
    Karen Harrington, Ph.D., HCLD (ABB), Hologic, Inc.
    Jonathan Genzen, M.D., Ph.D., MBA, ARUP Laboratories
    Allen Segal, J.D., American Society for °®¶¹´«Ã½
4:30–6:30 p.m.

Back to Top

 

Wednesday, Oct. 9


7:30–8 a.m.

Continental Breakfast

8–10 a.m.

Moderator: Elitza S. Theel, Ph.D., D(ABMM)

  • 8–8:50 a.m. | Epstein-Barr Virus and Multiple Sclerosis
    William Robinson, M.D., Ph.D., Stanford University School of Medicine

  • 8:50–9 a.m. | Q&A

  • 9–9:50 a.m. | Hot Topics in Virology
    Catherine Hogan, M.D., C.M., University of British Columbia
    Agatha Jassem, Ph.D., (D)ABMM, FCCM, University of British Columbia

  • 9:50–10 a.m. | Q&A
10 a.m.–2 p.m.

Exhibit and Poster Hall

  • 10–10:30 a.m. | Morning Break in Exhibit Hall

  • 12:30–1:30 p.m. | Luncheon in Exhibit Hall

  • 1:15–2 p.m. | Virology Jeopardy* in Exhibit Hall Theater
    Hosted by:
    Benjamin Pinsky, M.D., Ph.D., Stanford University School of Medicine, CVS 2024 Program Committee Chair
    Ryan Relich, Ph.D., Indiana University School of Medicine
10:15 a.m.–11 a.m.

Industry & Science Workshop*

  • 10:15-11 a.m. |

   
2:15–4:15 p.m.

  • Case Presenters:
    Hannah Wang, M.D., Cleveland Clinic
    Heba Mostafa, M.D., Ph.D., D(ABMM), The Johns Hopkins University School of Medicine
    Benjamin T. Bradley, M.D., Ph.D., University of Utah School of Medicine, and ARUP Laboratories
4:30–6:30 p.m.

Poster Session and Exhibit Hall Reception


4:30-6:30 p.m. | 

Back to Top

 

Thursday, Oct. 10


8–8:30 a.m.

Continental Breakfast

8:30–11:45 a.m.

Moderator: Melinda Poulter, Ph.D., University of Virginia School of Medicine

  • 8:30–9:15 a.m. | Primary HPV Screening for Cervical Cancer
    Nicolas Wentzensen, M.D., Ph.D., National Cancer Institute, Division of Cancer Epidemiology & Genetics

  • 9:15–10 a.m. | Nucleic Acid and Antibody-based Diagnostics for Viral Encephalitis
    Michael Wilson, M.D., UCSF Weill Institute for Neurosciences

  • 10–10:15 a.m. | Morning Break

  • 10:15–11 a.m. | Diagnosis of Congenital CMV
    Suresh Boppana, M.D., UAB Heersink School of Medicine

  • 11–11:45 a.m. | Novel Viral Diagnostic and Prognostic Techniques
    Kenneth Gavina, Ph.D., D(ABMM), SM(ASCP), Indiana University School of Medicine
11:45 a.m.–12 p.m.

Marilyn A. Menegus Award Presentation

12–1:45 p.m.

Lunch On Your Own

1:45–4:15 p.m.

Moderator: Xioatian Zhang, M.D., Akron Children's Hospital

  • 1:45–2:35 p.m. | Vaccination for the Prevention of Mosquito-Borne Viruses—Dengue, Chikungunya and Beyond
    Anna Durbin, M.D., The Johns Hopkins University School of Medicine

  • 2:35–3:25 p.m. | Re-Emergence of Measles Post-Pandemic and Strategies for Control
    David Sugerman, M.D., MPH, Centers for Disease Control and Prevention

  • 3:25–4:15 p.m. | Monoclonal Abs for RSV and other Respiratory Viruses
    Heidi Moline, M.D., MPH, Centers for Disease Control and Prevention
4:30–5:45 p.m.

 

  • Keynote Speaker Introduction
    Kenneth Gavina, Ph.D., D(ABMM), SM(ASCP), Indiana University School of Medicine

  • Highly Pathogenic Avian Influenza A(H5) Virus in the °®¶¹´«Ã½ States
    Marie Kirby, Ph.D., U.S. Centers for Disease Control and Prevention

  • Closing Remarks
    Rangaraj Selvarangan, Ph.D., D(ABMM), FIDSA, FAAM
    CVS 2024 Program Committee Vice Chair
5:45–7 p.m.

Free Time/Dinner On Your Own

7–10 p.m.

Back to Top

*Held in Exhibit Hall Theater

Twitter Feed